Overcoming the technical challenge of venous resection with pancreatectomy: Which factors determine survival?

IF 2.9 2区 医学 Q2 ONCOLOGY Ejso Pub Date : 2025-08-01 Epub Date: 2025-01-23 DOI:10.1016/j.ejso.2025.109629
Elena B. Rangelova , Poya Ghorbani , Roberto Valente , Kimitaka Tanaka , Asif Halimi , Urban Arnelo , Ralf Segersvärd , Ernesto Sparrelid , Marco Del Chiaro
{"title":"Overcoming the technical challenge of venous resection with pancreatectomy: Which factors determine survival?","authors":"Elena B. Rangelova ,&nbsp;Poya Ghorbani ,&nbsp;Roberto Valente ,&nbsp;Kimitaka Tanaka ,&nbsp;Asif Halimi ,&nbsp;Urban Arnelo ,&nbsp;Ralf Segersvärd ,&nbsp;Ernesto Sparrelid ,&nbsp;Marco Del Chiaro","doi":"10.1016/j.ejso.2025.109629","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Pancreatectomy with venous resection (PVR) is nowadays considered standard. However, there is still concern about increased postoperative morbidity and impaired long-term outcome depending on the type of venous resection and reconstruction. The aim was to investigate the predictors of morbidity and long-term survival in patients undergoing PVR in a high-volume center.</div></div><div><h3>Methods</h3><div>All consecutive patients undergoing PVR at a single center between January 2008 and January 2019 were retrieved from a prospectively maintained database. Factors associated with postoperative complications and long-term survival were analyzed.</div></div><div><h3>Results</h3><div>Of 290 patients with isolated PVRs, 188 (65 %) were performed for pancreatic ductal adenocarcinoma (PDAC). Surgical complications developed in 56 % of patients (n = 163), and 11 % (n = 36) had severe complications (Clavien-Dindo&gt;3a). The 90-day mortality was 4.1 %. Venous thrombosis occurred in 4.8 % (n = 14), resulting in one mortality (0.3 %). No technical factors were predictive for the development of severe complications. Longer vein segments &gt;3 cm could be resected with similar short- and long-term outcome as shorter segments. The survival of patients undergoing PVR for resectable, borderline and locally advanced PDAC was similar (median of 18, 14, and 23 months, p = 0.7). On multivariate analysis, elevated CA19-9&gt;200 U/mL and ASA score≥3 were independent predictors of survival (p = 0.02), but not resectability at diagnosis nor type of venous reconstruction.</div></div><div><h3>Conclusion</h3><div>The type of venous resection/reconstruction does not influence outcome and should be tailored according to patients' and tumors’ characteristics during PVR. The long-term survival after PVR for PDAC is influenced by tumor-and patient-related characteristics, and not technical vascular-resection associated factors.</div></div>","PeriodicalId":11522,"journal":{"name":"Ejso","volume":"51 8","pages":"Article 109629"},"PeriodicalIF":2.9000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ejso","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0748798325000575","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/23 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Pancreatectomy with venous resection (PVR) is nowadays considered standard. However, there is still concern about increased postoperative morbidity and impaired long-term outcome depending on the type of venous resection and reconstruction. The aim was to investigate the predictors of morbidity and long-term survival in patients undergoing PVR in a high-volume center.

Methods

All consecutive patients undergoing PVR at a single center between January 2008 and January 2019 were retrieved from a prospectively maintained database. Factors associated with postoperative complications and long-term survival were analyzed.

Results

Of 290 patients with isolated PVRs, 188 (65 %) were performed for pancreatic ductal adenocarcinoma (PDAC). Surgical complications developed in 56 % of patients (n = 163), and 11 % (n = 36) had severe complications (Clavien-Dindo>3a). The 90-day mortality was 4.1 %. Venous thrombosis occurred in 4.8 % (n = 14), resulting in one mortality (0.3 %). No technical factors were predictive for the development of severe complications. Longer vein segments >3 cm could be resected with similar short- and long-term outcome as shorter segments. The survival of patients undergoing PVR for resectable, borderline and locally advanced PDAC was similar (median of 18, 14, and 23 months, p = 0.7). On multivariate analysis, elevated CA19-9>200 U/mL and ASA score≥3 were independent predictors of survival (p = 0.02), but not resectability at diagnosis nor type of venous reconstruction.

Conclusion

The type of venous resection/reconstruction does not influence outcome and should be tailored according to patients' and tumors’ characteristics during PVR. The long-term survival after PVR for PDAC is influenced by tumor-and patient-related characteristics, and not technical vascular-resection associated factors.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
克服静脉切除胰切除术的技术挑战:哪些因素决定生存?
背景:胰切除术加静脉切除术(PVR)目前被认为是标准的。然而,根据静脉切除和重建的类型,仍然存在术后发病率增加和长期预后受损的担忧。目的是研究在大容量中心进行PVR患者的发病率和长期生存的预测因素。方法:从一个前瞻性维护的数据库中检索2008年1月至2019年1月在单一中心连续接受PVR的所有患者。分析术后并发症及远期生存率的相关因素。结果:在290例分离性PVRs患者中,188例(65%)因胰腺导管腺癌(PDAC)接受了手术。56%的患者(n = 163)出现手术并发症,11% (n = 36)出现严重并发症(Clavien-Dindo>3a)。90天死亡率为4.1%。静脉血栓形成发生率为4.8% (n = 14),导致1例死亡(0.3%)。没有技术因素可以预测严重并发症的发生。较长的静脉段> ~ 3cm可以切除,短期和长期结果与较短的静脉段相似。可切除、交界期和局部晚期PDAC患者接受PVR的生存期相似(中位为18、14和23个月,p = 0.7)。在多因素分析中,CA19-9升高200 U/mL和ASA评分≥3是生存的独立预测因素(p = 0.02),但在诊断时可切除性和静脉重建类型方面没有影响。结论:静脉切除/重建的类型不影响预后,在PVR中应根据患者和肿瘤的特点量身定制。PDAC的PVR后的长期生存受肿瘤和患者相关特征的影响,而不是技术性的血管切除术相关因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Ejso
Ejso 医学-外科
CiteScore
6.40
自引率
2.60%
发文量
1148
审稿时长
41 days
期刊介绍: JSO - European Journal of Surgical Oncology ("the Journal of Cancer Surgery") is the Official Journal of the European Society of Surgical Oncology and BASO ~ the Association for Cancer Surgery. The EJSO aims to advance surgical oncology research and practice through the publication of original research articles, review articles, editorials, debates and correspondence.
期刊最新文献
Tumour localization and oncological outcomes in nonuterine leiomyosarcoma of the abdomen and pelvis Factors influencing surgical decision-making in breast cancer: A multicenter study in Japan The utility of large language models in oncological multidisciplinary team meetings: A systematic review Global burden, trends, and attributable risk factors of women's cancers with projection to 2050: Results from the GLOBOCAN 2022 and global burden of disease study 2021 Microwave ablation versus surgical resection for hepatocellular carcinoma within Milan criteria: A propensity score–based analysis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1